Two items of recent pandemic news: Sanofi & GSK get some good news from a Phase II study of their reformulated vaccine candidate; and questions swirl anew around the origins of the pandemic virus. Plus news briefs and a frippery. … Continue reading →
Three items of pandemic news you may have missed recently: Post-vaccination breakthrough infections are less than 0.008%; researchers estimate how much virus an infection produces; and an advisory committee punts on J&J. Plus news briefs and a frippery. Advisory committee … Continue reading →
There has been a lot of noise regarding the news reports that Congressman Stephen Lynch tested positive even though he had received both doses of the Pfizer vaccine. There is nothing newsworthy there — here‘s why. Despite some clumsy reporting … Continue reading →
